Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


MedaRed
1650 Owens St. #259
San Francisco, CA 94158
Phone: 650-793-7447

MedaRed is a biotechnology company focused on discovering and developing new therapeutics targeting fibrin. MedaRed is founded upon the pioneering work of Dr. Katerina Akassoglou, PhD, Senior Investigator at Gladstone Institutes and Professor of Neurology at the University of California, San Francisco. Dr. Akassoglou and colleagues discovered that fibrin, a blood-clotting factor, is implicated in the toxic inflammation that damages neurons in neurological diseases including Alzheimer's disease (AD) and multiple sclerosis (MS). MedaRed's key technology was invented by its co-founder Katerina Akassoglou, PhD, who discovered molecules that reduce neuroinflammation and the subsequent damage to neurons.

Key Contact
NameTitleE-Mail
Daniel BurgessCEO


Funding Events
DateAmountTypeInvestors
07/09/19$6,500,000Seed Dementia Discovery Fund  
Dolby Family Ventures  
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.